| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.26B | +33.9% |
| R&D Expense | $269.8M | +22.7% |
| SG&A Expense | $195.9M | +9.2% |
| Operating Income | -$39.1M | +65.8% |
| Pre-tax Income | -$30.3M | +73.0% |
| Income Tax | $6.7M | +14.0% |
| Net Income | -$37.0M | +68.6% |
| EPS (Basic) | -$0.19 | +70.8% |
| EPS (Diluted) | -$0.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $368.1M | +13.7% |
| Current Assets | $897.5M | -3.7% |
| Total Assets | $1.01B | -2.3% |
| Current Liabilities | $329.0M | -10.3% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $347.4M | -31.5% |
| Stockholders' Equity | $665.5M | +25.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $194.5M | +462.9% |
| Capital Expenditures | $6.0M | +109.9% |
| Investing Cash Flow | -$17.7M | +64.6% |
| Financing Cash Flow | -$127.4M | -200.6% |
| Free Cash Flow | $188.5M | +433.9% |
| +70.8% |